You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
13 August 2026 - US biopharmaceutical company PTC Therapeutics Inc (NASDAQ:PTCT) announced on Wednesday that it was selected as the winning bidder to acquire ST-920, a BLA-stage, one-time administered AAV gene therapy for Fabry disease, from Sangamo ...
12 August 2026 - Swedish pharmaceutical company EQL Pharma AB (STO: EQL) announced on Wednesday that it has licensed its methenamine hippurate product Memprex for sale in Hungary through local pharmaceutical company Pharmacenter, which develops and c...
12 August 2026 - Cell-free DNA and precision medicine company Natera Inc (NASDAQ:NTRA) said on Wednesday that it will provide its Latitude tissue-free molecular residual disease (MRD) assay for a Phase 1 clinical trial sponsored by Kupando Therapeuti...
12 August 2026 - Swedish biotech company AlzeCure Pharma AB (FN STO:ALZCUR) announced on Wednesday that it has received the full USD12m upfront payment from Danish biotech company QuantumCell ApS under their licensing and collaboration agreement for ...
12 August 2026 - Graviton BioScience Corporation, a privately held, clinical-stage biotechnology company developing a diverse pipeline of therapeutics, including selective ROCK2 inhibitors for metabolic, inflammatory, fibrotic, and central nervous sy...
12 August 2026 - Galvanize Therapeutics Inc, a commercial-stage medical technology company focused on pulsed electric field (PEF) therapies for oncology and chronic lung disease, announced on Tuesday the completion of the first commercial procedures ...